HIGHPOC
CVE-2000-1009
NVD-CWE-OtherPublished: December 11, 2000· Updated: Jun 16, 2026
7.2
CVSS v3.1
Official Description
dump in Red Hat Linux 6.2 trusts the pathname specified by the RSH environmental variable, which allows local users to obtain root privileges by modifying the RSH variable to point to a Trojan horse program.
Technical Analysis
CVE-2000-1009 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
A proof-of-concept (PoC) exploit exists for CVE-2000-1009. While not yet confirmed in active campaigns, the availability of PoC code increases exploitation risk substantially.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorLocal
Attack ComplexityLow
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityC
IntegrityC
AvailabilityC
AV:L/AC:L/Au:N/C:C/I:C/A:C
Affected Vendors & Products
Exploit & PoC Resources
POC AVAILABLEProof-of-concept code exists
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (6)
→
http://www.securityfocus.com/bid/1871Exploit · Patch · Vendor Advisory
→
http://www.securityfocus.com/bid/1871Exploit · Patch · Vendor Advisory
Quick Facts
CVE IDCVE-2000-1009
CVSS Score7.2 / 10
SeverityHIGH
WeaknessNVD-CWE-Other
CISA KEVNo
ExploitPOC
Affected2 vendor(s)
PublishedDec 11, 2000
Related CVEs (NVD-CWE-Other)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2000-1009 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.